Skip to content

Rani Therapeutics

Request correction

Clinical-stage biotherapeutics company developing the RaniPill® robotic capsule to enable oral delivery of biologics.

Last updated September 16, 2026

AI crawler reads

2requests

1companies
  • Anthropic2
Profile
2
Controversies
0
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

Rani Therapeutics is a clinical-stage biotherapeutics company developing technology to enable orally administered biologics and drugs. Its RaniPill® is a simple-to-swallow robotic capsule designed to deliver biologics orally with injectable-like bioavailability. The company was established after several years as a research project within InCube Labs, Mir Imran's life sciences lab. Rani reports 3 Phase 1 studies completed, 20 molecules assessed in preclinical work, and 400+ granted and pending patents.

History

Rani was established after several years as a research project within InCube Labs, Mir Imran's multi-disciplinary life sciences lab focused on developing and commercializing breakthrough innovations. Rani Therapeutics is a clinical-stage biotherapeutics company developing technology to enable orally administered biologics and drugs. Its RaniPill® addresses the 30-year-old "gastric barrier" problem: instead of chemical absorption methods that provide less than 1 percent bioavailability, Rani created a simple-to-swallow robotic capsule that delivers biologics through the intestinal wall, offering injectable-like bioavailability without a needle. The company reports 3 Phase 1 studies completed, 20 molecules assessed in preclinical work, and 400+ granted and pending patents.

Products and positioning

Developing technology to enable orally administered biologics and drugs, aiming to replace painful injections with a pill.

  • RaniPill®

    A simple-to-swallow robotic capsule that delivers biologics orally, offering injectable-like bioavailability; a swallowable auto-injector designed to protect biologic drugs through the stomach and deliver them directly and painlessly through the intestinal wall.

Recent events

  • Reported

    Rani Therapeutics appoints Lisa Rometty to its board[4]

    Rani Therapeutics announced Lisa Rometty’s appointment to its Board of Directors.

Read more

Sources4 sources

Cite this profile: Cite the canonical profile. /brand-wiki/rani-therapeutics-united-states · Editorial policy · How profiles are compiled